Pomegranate vs beetroot for blood pressure
Two of the strongest food-derived blood-pressure supplements, two completely different mechanisms. Pomegranate works through polyphenols (punicalagins, ellagitannins) that act on endothelial nitric-oxide signalling over weeks to months. Beetroot works through dietary nitrate, converted to nitric oxide via the salivary–nitrate–nitrite pathway, with measurable blood-pressure drop within 2–3 hours of intake. Both are Tier 2 supplements; both have meta-analyses; the right pick depends on whether you want an acute or chronic effect.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Daily BP reduction over weeks to months | Pomegranate | Sahebkar 2017 meta-analysis: 4.96 mmHg systolic, 2.01 mmHg diastolic reduction at 240+ mL/day or extract equivalent for ≥2 weeks. |
| Acute pre-exercise or pre-event BP lowering | Beetroot | Siervo 2013 meta-analysis: 4.4 mmHg systolic acute reduction within 2–3 hours of 5–8 mmol nitrate. |
| Athletic performance / exercise economy | Beetroot | Robust performance effect via nitrate-NO pathway; pomegranate has no comparable performance signal. |
| Vascular health beyond BP (oxidised LDL, endothelial function) | Pomegranate | Multiple trials show reduction in oxidised LDL, improvement in flow-mediated dilation, and slowed intima-media thickness progression in pilot trials. |
| Tolerability (no urine or stool discolouration) | Pomegranate | Beetroot reliably produces "beeturia" (pink urine) and reddish stool in a meaningful minority of users — harmless but startling. |
| Cost per effective dose | Beetroot (powder/juice) | Beetroot powder runs $0.30–0.60/day; pomegranate extracts standardised to punicalagins run $0.75–1.50/day. |
How they compare on the things that matter
Mechanism — what they actually do
Pomegranate's BP effect is driven by ellagitannins and their gut-microbiota-derived metabolites (urolithins), which appear to improve endothelial nitric-oxide bioavailability via reduced oxidative inactivation of NO and inhibition of angiotensin-converting enzyme in animal models. The effect builds over weeks; acute single-dose BP responses are small.
Beetroot's BP effect is much more direct. Dietary nitrate (NO3-) is reduced to nitrite (NO2-) by bacteria on the tongue, then to nitric oxide (NO) in tissues — particularly under low-oxygen conditions like working muscle. The effect is rapid (2–3 hour peak) and dose-dependent. Antiseptic mouthwash blocks the tongue-bacteria step and abolishes the effect, which is a useful tell for the mechanism.
Evidence base
- Pomegranate — Tier 2, evidence 3/5. Sahebkar 2017 meta-analysis of 8 RCTs found consistent SBP reduction (-4.96 mmHg, 95% CI -7.34 to -2.58). The Aviram 2004 carotid intima-media thickness pilot is supportive but small. Most positive trials use juice (240 mL/day) or standardised extracts; "pomegranate seed oil" is a different product with no BP signal.
- Beetroot / dietary nitrate — Tier 2, evidence 3/5. Siervo 2013 and Bahadoran 2017 meta-analyses confirm both acute and chronic SBP/DBP reductions. The DASH-Sodium trial design and subsequent nitrate-supplementation trials show consistent effects, with larger effects in untreated hypertensive subjects.
Safety and side-effects
Pomegranate at the trial dose (240 mL juice or 500–1000 mg extract daily) is well tolerated. Notable drug interactions include modest CYP3A4 inhibition — relevant for some statins, calcineurin inhibitors, and CYP3A4-cleared drugs; discuss with a pharmacist if you take a narrow-therapeutic-window CYP3A4 drug. The juice is high-sugar (a 240 mL serving contains ~30 g sugar) — diabetic patients may prefer extract capsules.
Beetroot is well tolerated. Beeturia (pink urine) and red stool are harmless but distinctive — worth knowing in advance to avoid alarm. Patients with calcium-oxalate kidney stones should approach beetroot cautiously (it's high oxalate). The nitrate–nitric-oxide pathway is theoretically additive with vasodilator medications (nitrates, PDE-5 inhibitors); patients on these drugs should discuss with their prescriber.
What the price difference buys you
Pomegranate juice (240 mL/day) runs $1.50–2.50/day at supermarket prices. Standardised pomegranate extract (POMx-equivalent, ~500 mg/day) runs $25–40/month — cheaper than juice and avoids the sugar load. Beetroot powder (10–15 g/day, providing 5–8 mmol nitrate) runs $10–18/month. Beetroot juice in single-serving "shot" form is more expensive and not necessary if you tolerate the powder.
Who should skip each
Pomegranate should be used with caution if you take CYP3A4 substrates with narrow therapeutic windows (tacrolimus, cyclosporine, some statins). It has not been shown to be problematic with most BP medications. Patients with diabetes should prefer extract over juice.
Beetroot should be used cautiously in calcium-oxalate kidney-stone formers (oxalate load). Patients on nitrate medications (isosorbide, nitroglycerin) or PDE-5 inhibitors (sildenafil, tadalafil) should discuss with their prescriber owing to additive vasodilation. Antiseptic mouthwash abolishes the effect — if you use chlorhexidine or similar, beetroot won't work.
What we'd actually buy
For chronic adjunct BP management alongside lifestyle changes and (if prescribed) antihypertensives: standardised pomegranate extract 500 mg/day, with food. Reassess BP at 6–8 weeks. The effect is modest (~5 mmHg systolic) — useful but not a substitute for prescribed medications when indicated.
For an acute-effect daily ritual or pre-exercise nitrate boost: beetroot powder providing 5–8 mmol nitrate (typically 10–15 g powder or one concentrated "shot") in the morning. Pair with a real cardiovascular care plan. Avoid antiseptic mouthwash use within 3–4 hours.
Sources
- Sahebkar A, et al. Effects of pomegranate juice on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017;115:149–161. PMID: 27888156
- Siervo M, et al. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J Nutr. 2013;143(6):818–826. PMID: 23596162
- Aviram M, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 2004;23(3):423–433. PMID: 15158307
- Kapil V, et al. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension. 2015;65(2):320–327. PMID: 25421976
- Bahadoran Z, et al. The nitrate-independent blood pressure-lowering effect of beetroot juice: a systematic review and meta-analysis. Adv Nutr. 2017;8(6):830–838. PMID: 29141968
- Asgary S, et al. Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother Res. 2014;28(2):193–199. PMID: 23633265